Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2009
12/31/2009US20090325882 Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
12/31/2009US20090325880 Tnf receptor-like molecules and uses thereof
12/31/2009US20090325875 Muteins of human tear lipocalin
12/31/2009US20090325873 Human glp-1 mimetibodies, compositions, methods and uses
12/31/2009US20090325872 Use of alpha-lactalbumin for regulations of glycemia
12/31/2009US20090325871 Role of the Mk2 Pathway in Wound Repair
12/31/2009US20090325870 Foamy viral envelope genes
12/31/2009US20090325869 Synthetic regulators of ferritin protein nanocage pores and methods of use thereof
12/31/2009US20090325867 Receptor-specific tumour necrosis factor-related apoptosis-inducing ligand (trail) variants
12/31/2009US20090325866 Non-activated wnt inhibition polypeptides and method for preparing the same
12/31/2009US20090325864 Novel protein and process for preparing the same
12/31/2009US20090325815 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
12/31/2009US20090325708 Biometric broadband gaming system and method
12/31/2009US20090325314 N-Methyl Scanning Mutagenesis
12/31/2009US20090325313 Two helix binders
12/31/2009US20090325310 Innovativer TSH-R-Ab-Kit
12/31/2009US20090325259 Use of adhesion molecules as bond stress-enhanced nanoscale binding switches
12/31/2009US20090325228 Fungal cell wall synthesis gene
12/31/2009US20090325187 Immunomodulation
12/31/2009US20090325170 Means and methods for diagnosing and/or treating a subject at risk of developing heart failure
12/31/2009US20090325162 Fatty acid synthetase, polynucleotide encoding the same, and uses thereof
12/31/2009US20090324700 Methods and compositions for the inhibition of cathepsins
12/31/2009US20090324677 Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1
12/31/2009US20090324650 Method for The Production of Hydrolyzed Allergen
12/31/2009US20090324649 Leishmania vaccine using sand fly salivary immunogen
12/31/2009US20090324634 Trypanosoma Antigens, Vaccine Compositions, and Related Methods
12/31/2009US20090324633 Immunogens from Uropathogenic Escherichia Coli
12/31/2009US20090324632 Methods and reagents for vaccination which generate a CD8 T cell immune response
12/31/2009US20090324631 Polyvalent Vaccine
12/31/2009US20090324630 Fusion multiviral chimeric antigen
12/31/2009US20090324628 Compounds useful in the diagnosis and treatment of malaria
12/31/2009US20090324627 ISOLATED DNA DIRECTED 50kD REGULATORY SUBUNIT (POLD2) GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM CHOMOSOME 7 AND THEIR USES
12/31/2009US20090324626 Isolated snare ykt6 genomic polynucleotide fragments from chomosome 7 and their uses
12/31/2009US20090324622 Antibody vaccine conjugates and uses therefor
12/31/2009US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity
12/31/2009US20090324597 Unique long 16 (UL-16)-binding proteins (ULBP) specific immunoglobulin for use in diganosis cell proliferative disorders
12/31/2009US20090324590 Myostatin antagonists
12/31/2009US20090324566 T-Cell Receptor and Nucliec Acid Encoding the Receptor
12/31/2009US20090324562 Defensin Proteins
12/31/2009US20090324556 Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof
12/31/2009US20090324553 Chimeric Viral Envelopes
12/31/2009US20090324538 Fusion molecules and IL-15 variants
12/31/2009US20090324501 Vaccine Carrier
12/31/2009US20090324492 Treatment for Central Nervous System Disorders
12/31/2009DE102008027004A1 New polymer peptide conjugate comprising a side chain, useful for controlling and studying in vitro- and in vivo processes and for drug delivery applications
12/30/2009WO2009158696A1 SOLUBLE HYBRID Fcγ RECEPTORS AND RELATED METHODS
12/30/2009WO2009158614A1 Novel astrovirus
12/30/2009WO2009158591A1 Strong activation domain
12/30/2009WO2009158470A2 Toxin genes and methods for their use
12/30/2009WO2009158433A1 Regulating the production of long chain hydrocarbons
12/30/2009WO2009158240A1 Salmonella vectored vaccines against chlamydia and methods of use
12/30/2009WO2009157926A1 Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof
12/30/2009WO2009157869A1 Enamel matrix derivative fraction c
12/30/2009WO2009157684A2 Gsl8 and use thereof
12/30/2009WO2009157602A1 The recombinant chimeric protein for the diagnosis of taenia solium infection and diagnostic kits comprising the same toward a standardized serodiagnosis of taenia solium neurocysticercosis
12/30/2009WO2009157399A1 Sulfonamide compound or salt thereof
12/30/2009WO2009157000A1 TOMATO SlMYB12 TRANSCRIPTION FACTOR AND GENETIC SELECTION THEREOF
12/30/2009WO2009156545A1 Plastidial thioredoxins: overexpression and biotechnological applications
12/30/2009WO2009156544A1 Complexes of albumin with omega-9 monounsaturated fatty acids for treatment of medullary lesions
12/30/2009WO2009156511A2 N-glycosylated human growth hormone with prolonged circulatory half-life
12/30/2009WO2009156473A1 Derivatised hybrid peptides of amylin and salmon calcitonin
12/30/2009WO2009156456A1 Muteins of hngal and related proteins with affinity for a given target
12/30/2009WO2009156448A1 Attenuated pestivirus
12/30/2009WO2009156430A1 A process of purifying coagulation factor viii
12/30/2009WO2009156405A1 Novel immunoadjuvant flagellin-based compounds and use thereof
12/30/2009WO2009156371A1 Genes for modulating coffee maturation and methods for their use
12/30/2009WO2009156367A1 Recombinant herpesvirus of turkeys encoding for interleukin-12
12/30/2009WO2009156360A1 Plants having enhanced yield-related traits and a method for making the same
12/30/2009WO2009156179A1 Her3 as a determinant for the prognosis of melanoma
12/30/2009WO2009156171A1 Met agonists
12/30/2009WO2009156137A1 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life
12/30/2009WO2009155842A1 Fusion protein of onconase and toxin transmembrane domain and preparation method and use thereof
12/30/2009WO2009155789A1 Polypeptides and derivatives thereof that inhibit hiv infection
12/30/2009WO2009155709A1 Bridged secondary amines and use thereof as iap bir domain binding compounds
12/30/2009WO2009155633A1 Method of producing yeast biomass
12/30/2009WO2009155626A2 Functionally intact fibrinogen remaining stable during storage
12/30/2009WO2009140418A3 Compositions and methods for treating arthritis and/or diseases involving cartilage degeneration
12/30/2009WO2009137145A9 Transcriptional control in alicyclobacillus acidocaldarius and associated genes, proteins, and methods
12/30/2009WO2009127072A8 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
12/30/2009WO2009124353A8 Modified cpn10 and prr signalling
12/30/2009WO2009120366A3 Algal glycerol-3 phosphate acyltransferase
12/30/2009WO2009120313A3 Identification of human t2r receptors that respond to bitter ligands in soy and related assays for identifying bitter taste modulators
12/30/2009WO2009120043A3 Use for cd45+ cells or a cd45+ cell culture fluid for promoting the growth of mesenchymal stem cells
12/30/2009WO2009105084A3 Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof
12/30/2009WO2009086352A3 Cynomolgus toll-like receptor 3
12/30/2009WO2009085169A3 Diacylglycerol acyltransferase 2 genes and proteins encoded thereby from algae
12/30/2009WO2009078977A9 Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins
12/30/2009WO2009076388A3 Targeting vector-phospholipid conjugates
12/30/2009WO2009070507A3 Anaplasma phagocytophilum (aph) antigens and antibodies specific for anaplasma
12/30/2009WO2009067177A3 Bone morphogenic protein binding peptide
12/30/2009WO2009059011A9 Hla-dr binding peptides and their uses
12/30/2009WO2009055688A3 Vaccine targets and delivery systems for cryptosporidium
12/30/2009WO2009039413A3 Methods and compositions for detection of ehrlichia chaffeensis (p120)
12/30/2009WO2009038729A3 Compositions and methods utilizing fibrin beta chain fragments of the bbeta chain of fibrinogen
12/30/2009WO2009025867A3 Compositions of humanized notch fusion proteins and methods of treatment
12/30/2009WO2009018477A3 Methods of inhibiting calcineurin with apoe analogs
12/30/2009WO2009012487A3 Chimeric varicella zoster virus-virus like particles
12/30/2009WO2009008912A3 Mycobacterial mutants inducing il-12
12/30/2009WO2008118545A3 Methods for generating novel stabilized proteins
12/30/2009WO2005040229A3 Ldl receptor class a and egf domain monomers and multimers
1 ... 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 ... 2916